Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.62 |
| ▸ | APP | P05067 | 7/20 | 0.62 |
| ▸ | VDR | P11473 | 4/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 7/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.48 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | HTT | P42858 | 4/20 | 0.48 |
| ▸ | MMP14 | P50281 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 3/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | INSR | P06213 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | ALPG | P10696 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13245094 | 1.00 | MAPT (0.62) | MAPTAPPVDRRELAMEN1 | |
| Iodide SCHEMBL7758713 | 0.99 | MAPT (0.62) | MAPTAPPVDRRELAMEN1 | |
| Iodide SCHEMBL7758714 | 0.99 | MAPT (0.62) | MAPTAPPVDRRELAMEN1 | |
| SCHEMBL1405400 | 0.92 | APP (0.53) | MAPTAPPVDRRELAMEN1 | |
| SCHEMBL1405401 | 0.92 | APP (0.53) | MAPTAPPVDRRELAMEN1 | |
| SCHEMBL25664248 | 0.90 | MAPT (0.72) | MAPTAPPVDRRELAMEN1 | |
| SCHEMBL6128356 | 0.88 | MAPT (0.60) | MAPTAPPVDRRELAMEN1 | |
| Perchlorate SCHEMBL1532818 | 0.87 | KMT2A (0.54) | MAPTAPPVDRRELAMEN1 | |
| Perchlorate SCHEMBL1532815 | 0.87 | KMT2A (0.54) | MAPTAPPVDRRELAMEN1 | |
| Perchlorate SCHEMBL29959735 | 0.87 | KMT2A (0.54) | MAPTAPPVDRRELAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9730876-B2 | Process for dyeing keratin fibres comprising a dye-pigment, a photoactive compound and a light source | L'OREAL (FR) | 2017-08-15 | — | — | US | disclosed |
| US-20150224041-A1 | PROCESS FOR DYEING KERATIN FIBRES COMPRISING A DYE-PIGMENT, A PHOTOACTIVE COMPOUND AND A LIGHT SOURCE | L'OREAL (FR) | 2015-08-13 | — | — | US | disclosed |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2012-02-09 | — | — | US | disclosed |
| US-7754863-B2 | Metal complex compounds for the optical recording, storage and playback of information; satisfactory sensitivity and recording properties, especially at high recording speeds | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-07-13 | — | — | US | disclosed |
| US-20070248782-A1 | High-Capacity Optical Storage Media | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150224041-A1 | PROCESS FOR DYEING KERATIN FIBRES COMPRISING A DYE-PIGMENT, A PHOTOACTIVE COMPOUND AND A LIGHT SOURCE | KRT18, IK, CUTA | MAPT 236/4885APP 335/4885VDR 2295/4885 |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | SNCA, PSEN1, CDR2 | MAPT 43/4885APP 15/4885VDR 3185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.